ArticleslgStudy

chemistry

SDZ 208-912

SDZ 208-912 is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand SDZ 208-912 rather than just read about it. In short: SDZ 208-912 is an experimental antipsychotic of the ergoline family which was under development for the treatment of psychotic disorders but was never marketed. Its route of administration is unknown.

SDZ 208-912 — main illustration
SDZ 208-912 — illustration

Key takeaways

  • SDZ 208-912 belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect SDZ 208-912 to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of SDZ 208-912 from memory before moving on to harder problems.

Reference excerpt

SDZ 208-912 is an experimental antipsychotic of the ergoline family which was under development for the treatment of psychotic disorders but was never marketed. Its route of administration is unknown. The drug shows high affinity for the dopamine D2 receptor, α1-adrenergic receptor, and serotonin 5-HT1A receptor, as well as somewhat lower affinity for the dopamine D1 receptor, α2-adrenergic receptor, and serotonin 5-HT2 receptor. It acts as a weak partial agonist of the dopamine D2 and D3 receptors. SDZ 208-912 inhibits dextroamphetamine-induced hyperlocomotion and apomorphine-induced compulsive gnawing in rodents. It has a low or negligible propensity for causing catalepsy. The drug strongly suppresses prolactin levels and produces antiparkinsonian-like effects in rodents. SDZ 208-912 was first described in the scientific literature by 1988. It was under development by Novartis. The drug reached phase 2 clinical trials for psychotic disorders in the United States and European Union prior to the discontinuation of its development in 1998.

See also List of investigational antipsychotics Terguride (transdihydrolisuride)

References

Illustrations

SDZ 208-912 illustration

Worked examples

Example 1 — a first encounter with SDZ 208-912

Start with the simplest possible case. Write down what SDZ 208-912 claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to SDZ 208-912 before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about SDZ 208-912 ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of SDZ 208-912

In research
SDZ 208-912 appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses SDZ 208-912 in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
SDZ 208-912 is common in secondary-school and first-year university syllabi. It links to neighbouring topics Abandoned drugs, Adrenergic receptor modulators, Chloroarenes, so understanding it makes those chapters shorter.
In everyday life
Look for SDZ 208-912 outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “SDZ 208-912” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study SDZ 208-912 in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what SDZ 208-912 means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain SDZ 208-912 out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is SDZ 208-912 in simple terms?

SDZ 208-912 is an experimental antipsychotic of the ergoline family which was under development for the treatment of psychotic disorders but was never marketed. Its route of administration is unknown.

Why does SDZ 208-912 matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study SDZ 208-912?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on SDZ 208-912.

Tags

  • Abandoned drugs
  • Adrenergic receptor modulators
  • Chloroarenes
  • D2 receptor agonists
  • D3 receptor agonists
  • Dopamine receptor modulators
  • Drugs not assigned an ATC code
  • Ergolines
  • Methyl compounds
  • Propionamides
  • Serotonin receptor modulators
  • Substituted 9,10-dihydroergolines

Keep exploring